[Pharmaceutical Indication Service in a case of palmar-plantar erythema after amoxicillin and ibuprofen treatment].

IF 0.6 Q4 HEALTH POLICY & SERVICES Farmaceuticos Comunitarios Pub Date : 2024-09-19 eCollection Date: 2024-10-15 DOI:10.33620/FC.2173-9218.(2024).22
Lola Parra-Astorgano
{"title":"[Pharmaceutical Indication Service in a case of palmar-plantar erythema after amoxicillin and ibuprofen treatment].","authors":"Lola Parra-Astorgano","doi":"10.33620/FC.2173-9218.(2024).22","DOIUrl":null,"url":null,"abstract":"<p><strong>Case description: </strong>Patient (29 years old) with palmo-plantar erythema, goes to the community pharmacy (FC) requesting a cream to treat atopy.</p><p><strong>Evaluation: </strong>The patient accessed the Pharmaceutical Indication Service (SPIF), showing that the manifestations appeared 24 hours after the start of dental treatment with amoxicillin 1g/12h and ibuprofen 600 mg/8h without any concomitant medication.</p><p><strong>Intervention: </strong>After explaining the possible relationship of the symptoms with their medication, patient was derived to the doctor with the referral report completed by SEFAC-eXPERT.</p><p><strong>Results: </strong>The patient went to the emergency where she was treated with intravenous corticosteroid and a prescription for cetirizine 10 mg. The dentist changed the beta-lactam to a macrolide (azithromycin) and the ibuprofen to paracetamol. From the FC, the evolution of the symptoms was monitored, which took 72 hours to disappear. Allergy tests suggested avoiding beta-lactams, cephalosporins, and arylpropionics without being conclusive. Months later, the patient suffered similar symptoms after inhaling a disinfectant spray and the allergy diagnosis was confirmed.</p><p><strong>Conclusions: </strong>The FC identified and immediately referred using SPIF a case of hypersensitivity in a patient susceptible to RNM and the SPIF helps to record the intervention and follow-up, increasing patient safety.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"83-87"},"PeriodicalIF":0.6000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491920/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2024).22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Case description: Patient (29 years old) with palmo-plantar erythema, goes to the community pharmacy (FC) requesting a cream to treat atopy.

Evaluation: The patient accessed the Pharmaceutical Indication Service (SPIF), showing that the manifestations appeared 24 hours after the start of dental treatment with amoxicillin 1g/12h and ibuprofen 600 mg/8h without any concomitant medication.

Intervention: After explaining the possible relationship of the symptoms with their medication, patient was derived to the doctor with the referral report completed by SEFAC-eXPERT.

Results: The patient went to the emergency where she was treated with intravenous corticosteroid and a prescription for cetirizine 10 mg. The dentist changed the beta-lactam to a macrolide (azithromycin) and the ibuprofen to paracetamol. From the FC, the evolution of the symptoms was monitored, which took 72 hours to disappear. Allergy tests suggested avoiding beta-lactams, cephalosporins, and arylpropionics without being conclusive. Months later, the patient suffered similar symptoms after inhaling a disinfectant spray and the allergy diagnosis was confirmed.

Conclusions: The FC identified and immediately referred using SPIF a case of hypersensitivity in a patient susceptible to RNM and the SPIF helps to record the intervention and follow-up, increasing patient safety.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[阿莫西林和布洛芬治疗后掌跖红斑病例中的 "药用说明服务"]。
病例描述患者(29 岁)患有掌跖红斑,到社区药房(FC)要求购买治疗过敏症的药膏:评估:患者到药房(SPIF)就诊,显示在开始使用阿莫西林 1 克/12 小时和布洛芬 600 毫克/8 小时牙科治疗 24 小时后出现症状,且未同时使用任何药物:干预措施:向患者解释症状可能与药物治疗的关系后,患者带着SEFAC-eXPERT完成的转诊报告去看医生:结果:患者前往急诊就诊,接受了静脉皮质类固醇治疗,并获得了西替利嗪 10 毫克的处方。牙医将β-内酰胺类药物改为大环内酯类药物(阿奇霉素),布洛芬改为扑热息痛。从 FC 开始监测症状的发展,72 小时后症状才消失。过敏试验建议避免使用β-内酰胺类、头孢菌素类和芳基丙酸类药物,但没有得出结论。几个月后,患者在吸入消毒喷雾剂后出现类似症状,过敏诊断得到确认:家庭医生通过 SPIF 发现并立即转诊了一名对 RNM 过敏的患者,SPIF 有助于记录干预和随访情况,从而提高了患者的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Farmaceuticos Comunitarios
Farmaceuticos Comunitarios HEALTH POLICY & SERVICES-
CiteScore
0.40
自引率
33.30%
发文量
351
审稿时长
5 weeks
期刊最新文献
[OBSERVAFARMA: construyendo el futuro de los servicios profesionales farmacéuticos desde el presente]. [Validation of the JH-SEFAC Questionnaire on Knowledge on Insulin Management by Patients with Diabetes in Community Pharmacies]. [Professional Pharmaceutical Care Services. A case report]. [Analysis and categorization of pharmacotherapeutic queries received at a Valencia Drug Information Center]. [The relevant role of caregivers of patients using opioid analgesics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1